The FDA-cleared Res-Q technology is a point-of-care platform designed to prepare cell concentrates. Once prepared, the PRP is mixed with autograft or allograft bone prior to application.
Related Articles on Orthopedic Devices:
Ortho Kinematics Receives FDA Clearance on KineGraph Vertebral Motion Analyzer
56 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in December
AAOS Releases Technology Overview for Metal-on-Metal Hip Implants
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.